otcwiki

The Company announces the complete sale of the pharma services business which could impact the IDXG Stock . For more information regarding the Company's business, visit OTC Wiki.  Interpace Biosciences Inc is a leading company that specializes in enabling personalized medicinal products. This Company has closed a definitive asset purchase agreement under the Flagship of Biosciences Inc. It has acquired the Company's pharma services business.  The Company will also use the proceeds from the transaction for working capital requirements and investments to help drive the growth of its molecular diagnostics business. The president and CEO of the Company also announced that with the completion of the multiple transactions, we expect the Company to make progress. Moreover, the company's driven ash flow will focus on molecular diagnostics that the Company is offering the best in class solutions and other diagnostic insights. Besides providing the IDXG Stock, the Company determines

 Reconnaissance Africa is very pleased to announce the appointment of Michelle Borthwick for the position of Corporate Secretary. The company announces that Ms. Borthwick is corporate finance and governance professional with unending support and advice to the various Canadian general public listed companies. In the Toronto Stock Exchange, the Canadian Securities Exchange, and the multiple OTC Markets, she is the founder and the principal of Peakshore Counseling Incorporations. Since January 2013, she has been the vice president at several companies. She also plays her role as corporate finance of Fiore management, and the advisory group also added to this company. Before that, she was the only vice president and corporate secretary of the endeavor mining corporation. About Recon Africa: ReconAfrica is a Canadian oil and gas company engaged in the opening of the newly discovered deep Kavango Sedimentary Basin in the Kalahari Desert of northeastern Namibia and northwestern Botswa

 Artificial intelligence Technology Solutions Inc announces the fully owned subsidiaries. The robotic assistance devices have received orders from seventeen ROSA securities through the Company's largest dealers. For security, all the end users originate the hospital groups over the 00 different locations. The Company expects its users to be revealed within the next few months. However, the Sixteen ROSA units specified for this deployment will be configured as ROSA-P devices. Moreover, it is a new member of the ROSA lineup that uses existing light poles as its primary power source where the light may or may not be centrally controlled. The ROSA-P receives power from the pole during night-time hours when the fixture is active. But in the daylight, this unit then switches to auxiliary power by using its internal battery to ensure 24/7 coverage of the most secured area. This whole system will be deployed through the largest parking lots. Moreover, according to FBI data, the parki